查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086209

腸外營養市場：2026-2032年全球市場預測（依產品類型、成分、給藥途徑、治療時間、輸送方式、年齡層、應用及最終用戶分類）

Parenteral Nutrition Market by Product Type, Composition, Route Of Administration, Therapy Duration, Delivery Mode, Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腸外營養市場將成長至 120.8 億美元，複合年成長率為 5.74%。

主要市場統計數據
基準年 2025 81.6億美元
預計年份：2026年 85.7億美元
預測年份 2032 120.8億美元
複合年成長率 (%) 5.74%

腸外營養市場簡介

腸外全靜脈營養營養（TPN）和補充腸外營養（SPN），是無法透過胃腸道滿足營養需求的患者的重要治療方法。新生兒重症監護、腫瘤科、重症監護、腸道功能障礙、發炎性腸道疾病、重大手術以及長期家庭腸外營養計劃等領域的臨床需求都支持腸外營養。

腸外營養領域的變革性變化

該領域正從標準化的、以醫院為基礎的營養治療轉向個人化、基於方案且日益普及的居家營養治療。美國腸外腸內營養學會 (ASPEN) 和歐洲腸外腸內營養學會 (ESPEN) 的臨床指南強調了適當的患者選擇、感染預防、血糖管理以及對再營養風險、電解質紊亂、肝臟併發症和導管相關性血流感染的監測。

人工智慧對腸外營養的累積影響

人工智慧正透過臨床決策支援、最佳化配藥流程、庫存規劃和不利事件監測等方式，開始影響腸外營養。與電子健康記錄(EHR) 整合的工具有助於識別營養風險患者、預警電解質異常、輔助劑量計算並促進監測，但最終的腸外營養處方仍然是由臨床醫生主導的過程，需要藥劑師、註冊營養師和醫生的監督。

靜脈營養的主要區域趨勢

在亞太地區，由於中國、印度、日本、澳洲和韓國等國醫院基礎設施的擴建、重症監護能力的提升以及對先進臨床營養的投資，營養支持正蓬勃發展。雖然日本和澳洲的營養支持實踐較為成熟，醫院藥房管治也已完善，但中國和印度的腫瘤科、胃腸外科、新生兒科以及私立醫院網路對營養支持的需求正在不斷成長。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

儘管東協各國靜脈營養（PN）的發展環境不盡相同，但其潛力巨大。新加坡、泰國和馬來西亞在醫院容量、臨床營養應用和醫療旅遊方面處於主導，而印尼、越南和菲律賓則透過對醫療保健領域的廣泛投資來擴大服務覆蓋範圍。在海灣合作理事會（GCC）國家，先進的醫院系統、專科醫療中心、醫療旅遊策略以及政府主導的現代化計畫正在加速推動靜脈營養的普及。

主要國家腸外營養需求分析

美國在家庭腸外營養、特殊靜脈輸液和自動化配藥方面處於主導，其需求主要來自腸道功能障礙、腫瘤治療、重症監護、術後復健和新生兒重症監護。加拿大採用公共資金支持、以規範流程主導的模式，並建立了完善的臨床監管體系。墨西哥和巴西則透過分階段改善私立醫院、三級醫療中心、腫瘤科和醫院藥房的各項職能來擴大這些服務的覆蓋範圍。

為腸外營養領域的領導者提供的實用建議

產業領導者應優先考慮供應鏈韌性，具體措施包括：實現無菌注射劑來源多元化、加強品管體係以及提高對胺基酸、脂肪乳劑、電解質、維生素和微量元素的透明度。醫療機構需要規範腸外營養方案、投資營養支持團隊並利用已驗證的配藥檢驗來減少用藥錯誤、代謝併發症和導管相關感染疾病。

腸外營養分析的調查方法

本執行摘要基於對已發表的臨床營養指南、監管標準、醫療基礎設施指標、無菌注射用品供應趨勢、醫院藥房實踐以及腸外營養的安全性和療效等方面的證據進行系統性回顧。分析重點檢驗的因素，包括疾病負擔、醫院容量、報銷系統成熟度、臨床管治以及對家庭靜脈輸液治療的支持。

結論：腸外營養的策略展望

對於無法安全、充分接受口服營養的患者而言，腸外營養仍然是至關重要的治療選擇。隨著個人化配方、更安全的配藥方式、家庭靜脈輸液療法的擴展、脂肪乳劑的創新、即用型多腔輸液袋的出現，以及醫院和專科藥房臨床管治水平的提高，腸外營養市場不斷發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 腸外營養市場：依產品類型分類

  • 周邊靜脈營養
  • 全靜脈營養

第8章：腸外營養市場：依組成

  • 胺基酸溶液
  • 碳水化合物溶液
  • 電解液
  • 脂質乳劑
  • 維生素和微量元素溶液

第9章：靜脈營養市場：依給藥途徑分類

  • 中央線
  • 周邊管路

第10章：腸外營養市場：依治療持續時間分類

  • 短期
  • 長期

第11章：腸外營養市場：依給藥途徑分類

  • 風俗
    • 店內配藥
    • 外部給藥
  • 預混合料
    • 多腔袋
    • 單室袋

第12章 腸外營養市場：依年齡層別分類

  • 兒童
  • 成人
  • 老年人

第13章：腸外營養市場：依應用領域分類

  • 重症加護
  • 癌症營養
  • 手術營養

第14章 腸外營養市場：依最終用戶分類

  • 診所
  • 居家照護
  • 醫院

第15章 腸外營養市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 腸外營養市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 腸外營養市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Abbott Laboratories
  • Aculife Healthcare Pvt. Ltd.
  • Ajinomoto Co., Inc.
  • Albert David Limited
  • Amanta Healthcare
  • American Regent
  • Anhui Medipharm Co., Ltd.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Beximco Pharmaceuticals Ltd.
  • BML Parenteral Drugs
  • Claris Lifesciences Limited
  • Danone Nutricia
  • Eurofarma
  • Fresenius Kabi AG
  • Grifols SA
  • ICU Medical, Inc.
  • JW Pharmaceutical Corporation
  • Medtronic
  • Nestle Health Science
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Pharamed Healthcare
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sino-Swed Pharmaceutical Corp.
  • Terumo Corporation
  • Teva Pharmaceutical Industries
  • Vifor Pharma
Product Code: MRR-036C5CF3B549

The Parenteral Nutrition Market is projected to grow by USD 12.08 billion at a CAGR of 5.74% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.16 billion
Estimated Year [2026] USD 8.57 billion
Forecast Year [2032] USD 12.08 billion
CAGR (%) 5.74%

Parenteral Nutrition Market Introduction

Parenteral nutrition (PN), including total parenteral nutrition and supplemental parenteral nutrition, is an essential therapy for patients who cannot meet nutritional requirements through the gastrointestinal tract. Demand is supported by clinically defined need across neonatal intensive care, oncology, critical care, intestinal failure, inflammatory bowel disease, major surgery, and long-term home parenteral nutrition programs.

The parenteral nutrition market is shaped by sterile injectable manufacturing capacity, amino acid solutions, dextrose, electrolytes, vitamins, trace elements, lipid emulsions, multi-chamber bags, automated compounding, and hospital nutrition support teams. Adoption is closely tied to survival in complex care settings, the expansion of home infusion services, and guideline-driven emphasis on individualized nutrition therapy to reduce complications, preserve lean body mass, and support recovery.

Transformative Shifts in the Parenteral Nutrition Landscape

The landscape is shifting from standardized hospital-based PN toward personalized, protocol-driven, and increasingly home-enabled nutrition therapy. Clinical guidelines from ASPEN and ESPEN reinforce appropriate patient selection, infection prevention, glycemic management, and monitoring for refeeding risk, electrolyte imbalance, liver complications, and catheter-related bloodstream infections.

Manufacturers and providers are also adapting to persistent sterile injectable supply constraints, stronger quality requirements, and demand for ready-to-use multi-chamber bags that can reduce compounding burden. At the same time, specialty pharmacies and home infusion providers are investing in training, remote monitoring, and logistics capabilities to support safe parenteral nutrition administration outside acute care settings.

Cumulative Impact of Artificial Intelligence on Parenteral Nutrition

Artificial intelligence is beginning to influence parenteral nutrition through clinical decision support, compounding workflow optimization, inventory planning, and adverse-event surveillance. EHR-integrated tools can help identify patients at nutrition risk, flag electrolyte abnormalities, support dose calculations, and prompt monitoring, while final PN prescribing remains a clinician-led process requiring pharmacist, dietitian, and physician oversight.

The cumulative impact of AI is expected to be strongest where data quality is high and governance is mature. Automated checks for osmolarity, compatibility, dosing limits, renal or hepatic adjustments, and inventory availability can reduce avoidable variation. However, AI adoption must align with validated clinical protocols, cybersecurity requirements, medication safety standards, and transparent audit trails to avoid unsafe automation in a high-risk sterile injectable therapy.

Key Regional Insights for Parenteral Nutrition

Asia-Pacific is gaining momentum as hospital infrastructure expands, critical care capacity improves, and countries such as China, India, Japan, Australia, and South Korea invest in advanced clinical nutrition. Japan and Australia have mature nutrition support practices and established hospital pharmacy governance, while China and India are seeing rising demand from oncology, gastrointestinal surgery, neonatal care, and private hospital networks.

North America remains one of the most developed PN regions, supported by established home infusion reimbursement pathways, hospital compounding standards, nutrition support teams, and a large base of patients with complex chronic disease. Europe benefits from ESPEN-aligned clinical practice, sophisticated home parenteral nutrition programs, pharmacovigilance frameworks, and demand for multi-chamber bags, while Latin America is advancing through private healthcare investment, tertiary care expansion, and improving access in Brazil and Mexico.

The Middle East is expanding PN utilization through tertiary hospitals, medical tourism hubs, and government investment in specialized care, particularly in GCC markets. Africa remains comparatively underpenetrated because of infrastructure, affordability, cold-chain, and sterile compounding limitations, but targeted investment in neonatal care, oncology, intensive care, and hospital pharmacy capability is creating long-term opportunity.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN presents a mixed but promising PN environment, with Singapore, Thailand, and Malaysia leading in hospital capability, clinical nutrition adoption, and medical tourism, while Indonesia, Vietnam, and the Philippines expand access through broader healthcare investment. GCC countries are accelerating adoption through high-acuity hospital systems, specialist centers, medical tourism strategies, and government-backed modernization programs.

The European Union is a key regulatory and clinical hub, supported by harmonized quality expectations, pharmacovigilance, sterile preparation standards, and well-established clinical nutrition societies. BRICS countries offer scale and rising demand, especially through China, India, and Brazil, but local manufacturing resilience, affordability, reimbursement consistency, and hospital pharmacy capacity remain decisive factors.

G7 markets account for advanced PN use because of mature hospital systems, home infusion networks, specialist nutrition services, and high adoption of medication safety standards. NATO countries overlap significantly with high-income healthcare systems in North America and Europe, where supply security, sterile injectable resilience, procurement diversification, and critical care readiness have become strategic priorities.

Key Country Insights for Parenteral Nutrition Demand

The United States leads in home parenteral nutrition, specialty infusion, and automated compounding adoption, with demand shaped by intestinal failure, oncology, critical care, surgical recovery, and neonatal intensive care. Canada follows a publicly funded, protocol-driven model with strong clinical oversight, while Mexico and Brazil are expanding access through private hospitals, tertiary centers, oncology services, and gradual improvements in hospital pharmacy capability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain have well-developed clinical nutrition practices supported by specialist teams, home PN pathways, and safety-focused hospital pharmacy systems. Germany and France demonstrate strong specialty pharmacy and hospital infrastructure, the United Kingdom benefits from established intestinal failure services, Italy and Spain show broad use in tertiary care, and Russia maintains demand across large hospital networks, although access and procurement dynamics vary by region.

China and India represent major demand centers as surgical volumes, cancer care, intensive care services, and private hospital networks expand. Japan and South Korea have advanced hospital systems, strong quality expectations, and established clinical nutrition practices, while Australia combines mature home infusion capabilities with strong clinical governance for long-term PN patients.

Actionable Recommendations for Parenteral Nutrition Leaders

Industry leaders should prioritize supply resilience by diversifying sterile injectable sourcing, strengthening quality systems, and improving visibility into amino acids, lipid emulsions, electrolytes, vitamins, and trace elements. Providers should standardize PN protocols, invest in nutrition support teams, and use validated compounding checks to reduce medication errors, metabolic complications, and catheter-related infections.

Manufacturers and service providers should expand ready-to-use multi-chamber bag portfolios while preserving customization for complex patients. Strategic advancement will come from integrated hospital-to-home pathways, pharmacist-led monitoring, patient education, remote follow-up, and evidence generation demonstrating fewer complications, shorter hospital stays, and improved continuity of care.

Research Methodology for Parenteral Nutrition Analysis

This executive summary is developed from a structured review of clinical nutrition guidelines, regulatory standards, healthcare infrastructure indicators, sterile injectable supply dynamics, hospital pharmacy practices, and published evidence on parenteral nutrition safety and outcomes. The analysis emphasizes verifiable drivers such as disease burden, hospital capacity, reimbursement maturity, clinical governance, and home infusion readiness.

Market interpretation uses triangulation across therapy guidelines, manufacturer portfolios, healthcare policy signals, clinical practice patterns, regional access conditions, sterile preparation requirements, and technology adoption trends. Insights are qualitative and evidence-led, avoiding unsupported numerical claims while focusing on factors that reliably influence parenteral nutrition demand, adoption, and competitive positioning.

Conclusion: Strategic Outlook for Parenteral Nutrition

Parenteral nutrition remains a critical intervention for patients who cannot safely or adequately receive enteral nutrition. The market is advancing through individualized formulations, safer compounding, home infusion growth, lipid emulsion innovation, ready-to-use multi-chamber bags, and stronger clinical governance across hospitals and specialty pharmacies.

Future competitiveness will depend on reliable sterile injectable supply, validated digital tools, compliance with medication safety standards, and integrated care models that connect acute treatment with long-term monitoring. Organizations that combine clinical evidence, operational resilience, and patient-centered delivery will be best positioned in the evolving parenteral nutrition market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Parenteral Nutrition Market, by Product Type

  • 7.1. Peripheral Parenteral Nutrition
  • 7.2. Total Parenteral Nutrition

8. Parenteral Nutrition Market, by Composition

  • 8.1. Amino Acid Solution
  • 8.2. Carbohydrate Solution
  • 8.3. Electrolyte Solution
  • 8.4. Lipid Emulsion
  • 8.5. Vitamin And Trace Element Solutions

9. Parenteral Nutrition Market, by Route Of Administration

  • 9.1. Central Line
  • 9.2. Peripheral Line

10. Parenteral Nutrition Market, by Therapy Duration

  • 10.1. Short Term
  • 10.2. Long Term

11. Parenteral Nutrition Market, by Delivery Mode

  • 11.1. Custom
    • 11.1.1. On Site Compounding
    • 11.1.2. Outsourced Compounding
  • 11.2. Pre Mixed
    • 11.2.1. Multi Chamber Bags
    • 11.2.2. Single Chamber Bags

12. Parenteral Nutrition Market, by Age Group

  • 12.1. Pediatric
  • 12.2. Adult
  • 12.3. Geriatric

13. Parenteral Nutrition Market, by Application

  • 13.1. Critical Care
  • 13.2. Oncology Nutrition
  • 13.3. Surgical Nutrition

14. Parenteral Nutrition Market, by End User

  • 14.1. Clinics
  • 14.2. Homecare
  • 14.3. Hospitals

15. Parenteral Nutrition Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Parenteral Nutrition Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Parenteral Nutrition Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Abbott Laboratories
  • 19.2. Aculife Healthcare Pvt. Ltd.
  • 19.3. Ajinomoto Co., Inc.
  • 19.4. Albert David Limited
  • 19.5. Amanta Healthcare
  • 19.6. American Regent
  • 19.7. Anhui Medipharm Co., Ltd.
  • 19.8. Axa Parenterals Ltd.
  • 19.9. B. Braun Melsungen AG
  • 19.10. Baxter International Inc.
  • 19.11. Beximco Pharmaceuticals Ltd.
  • 19.12. BML Parenteral Drugs
  • 19.13. Claris Lifesciences Limited
  • 19.14. Danone Nutricia
  • 19.15. Eurofarma
  • 19.16. Fresenius Kabi AG
  • 19.17. Grifols S.A.
  • 19.18. ICU Medical, Inc.
  • 19.19. JW Pharmaceutical Corporation
  • 19.20. Medtronic
  • 19.21. Nestle Health Science
  • 19.22. Nipro Corporation
  • 19.23. Otsuka Pharmaceutical Co., Ltd.
  • 19.24. Pfizer Inc.
  • 19.25. Pharamed Healthcare
  • 19.26. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 19.27. Sino-Swed Pharmaceutical Corp.
  • 19.28. Terumo Corporation
  • 19.29. Teva Pharmaceutical Industries
  • 19.30. Vifor Pharma

LIST OF FIGURES

  • FIGURE 1. GLOBAL PARENTERAL NUTRITION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PARENTERAL NUTRITION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PARENTERAL NUTRITION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PARENTERAL NUTRITION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AMINO ACID SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AMINO ACID SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AMINO ACID SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARBOHYDRATE SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARBOHYDRATE SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARBOHYDRATE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ELECTROLYTE SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELECTROLYTE SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ELECTROLYTE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIPID EMULSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIPID EMULSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIPID EMULSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VITAMIN AND TRACE ELEMENT SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VITAMIN AND TRACE ELEMENT SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VITAMIN AND TRACE ELEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CENTRAL LINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CENTRAL LINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CENTRAL LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL LINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL LINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHORT TERM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SHORT TERM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SHORT TERM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LONG TERM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG TERM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LONG TERM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CUSTOM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CUSTOM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CUSTOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ON SITE COMPOUNDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ON SITE COMPOUNDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ON SITE COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OUTSOURCED COMPOUNDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OUTSOURCED COMPOUNDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OUTSOURCED COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PRE MIXED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PRE MIXED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PRE MIXED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MULTI CHAMBER BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MULTI CHAMBER BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MULTI CHAMBER BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE CHAMBER BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE CHAMBER BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE CHAMBER BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CRITICAL CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CRITICAL CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CRITICAL CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 283. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 284. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 293. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. ITALY PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. ITALY PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 314. ITALY PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. SPAIN PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 325. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 326. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 338. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 339. CHINA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. INDIA PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 345. INDIA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. INDIA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 347. INDIA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 348. INDIA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 349. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 350. INDIA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 351. INDIA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 352. INDIA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 353. INDIA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 354. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 355. JAPAN PARENTERAL NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 356. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 358. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 359. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2018-2032 (USD MILLION)
  • TABLE 360. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 361. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 362. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2018-2032 (USD MILLION)
  • TABLE 363. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 364. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2018-